Who manufactures Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Reckitt Benckiser (Healthcare) SA-NV (BE)

What ATC class does Gaviscon Adapted Formulation Mint 250 mg chewable tabl. belong to?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: ATC A02BX13 Alginic Acid. ATC is the WHO Anatomical Therapeutic Chemical classification.

OTC

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: Chewable tablet (Oral use)

Chewable tablet

INN: Sodium Alginate

Data updated: 2026-04-11

Tillgängligt i:

🇩🇪🇬🇧🇷🇴🇷🇺🇹🇷

Beredningsform

Chewable tablet

Dosering

—

Administreringsväg

Oral use

Förvaring

—

Om denna produkt

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.